Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $19,307 - $21,396
-87 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$215.77 - $276.76 $1.01 Million - $1.3 Million
-4,695 Reduced 98.18%
87 $471,000
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $1.05 Million - $1.26 Million
4,782 New
4,782 $1.23 Million
Q1 2020

Apr 29, 2020

SELL
$195.69 - $279.01 $2,348 - $3,348
-12 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $26,482 - $29,883
-112 Reduced 90.32%
12 $3.44 Million
Q3 2019

Nov 13, 2019

BUY
$230.58 - $256.08 $28,591 - $31,753
124 New
124 $30,000
Q2 2019

Aug 16, 2019

SELL
$217.4 - $246.08 $6,304 - $7,136
-29 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$206.05 - $248.17 $5,975 - $7,196
29 New
29 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $69.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.